查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2026916

痤瘡治療市場預測至2034年—全球產品類型、痤瘡類型、藥物類型、治療方法、給藥途徑、最終用戶和地區分析

Acne Treatment Market Forecasts to 2034 - Global Analysis By Product (Isotretinoi, Antibiotics, Retinoids and Other Products), Acne Type, Drug Type, Treatment, Route of Administration, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球痤瘡治療市場規模將達到 136 億美元，並在預測期內以 7.1% 的複合年成長率成長，到 2034 年將達到 236 億美元。

痤瘡是一種由毛孔和毛囊等皮膚開口堵塞引起的皮膚疾病。青少年和二十歲出頭的年輕人是主要受影響族群。痤瘡是一種極為常見的皮膚病，可影響所有膚質和年齡層的人。抗生素和類視色素藥物常用於治療痤瘡。雖然這些治療方法並不能保證達到預期效果，但由於其美容價值，製藥業多年來一直主導這一領域。

根據美國國家生物技術資訊中心（NCBI）的數據，截至2022年，全球9.4%的人口患有痤瘡。這使其成為全球第八大常見皮膚病。

痤瘡患病率增加

皮膚疾病影響許多人。隨著包括類視色素、異維A酸以及口服和外用抗生素在內的多種治療產品的出現，世界各地的人們對痤瘡治療產品和可用治療方案的了解日益增多。因此，患者意識的提高預計將推動市場擴張。有效吸引目標受眾的產品行銷也是推動市場成長的關鍵因素。

產品安全問題

痤瘡治療藥物的副作用因劑量和給藥方式而異。外用痤瘡藥物最常見的副作用是皮膚刺激和乾燥。口服藥物可能引起更嚴重的副作用。抗生素可能引起噁心、嘔吐、頭暈和頭暈。圍繞痤瘡治療方法的安全問題預計將阻礙市場擴張。

提高意識

人們對微創美容療程的需求日益成長。皮膚科醫生更傾向於使用外用藥物和微創技術來治療皮膚問題，而非手術。隨著決策能力的提高、醫病關係的改善以及醫療程序記錄的完善，臉部和皮膚相關問題的治療需求也在增加。這促使人們採用疼痛感更低、更全面的美容治療方法。

治療費用高昂

有效的痤瘡治療方法，尤其是涉及處方藥或雷射療法的治療，價格可能非常昂貴。這對於經濟條件有限或沒有醫療保險的人來說是一個很大的問題。痤瘡治療並非總是一次性支出；通常需要定期維護和後續觀察，這會增加某些治療的總成本。這些因素正在阻礙市場成長。

新型冠狀病毒（COVID-19）的影響：

疫情導致全球就診人數下降，減緩了痤瘡藥物需求的成長。受新冠疫情影響，業界主要公司的營收大幅下滑。此外，藥品銷售還受到產量下降、醫療支出分配變化、供應鏈中斷、皮膚科診所關閉以及其他因素的影響。而長期佩戴醫用口罩導致痤瘡發生率上升，進一步刺激了對藥物的需求。

在預測期內，治療設備領域預計將成為最大的細分市場。

在預測期內，治療設備領域預計將成為最大的細分市場。痤瘡治療設備的研發正在推動該產業的擴張。雷射治療痤瘡疤痕旨在減少痤瘡疤痕的可見度。透過持續光療照射皮膚真皮層，可以分解疤痕組織，並促進新的健康皮膚細胞生長以取代受損組織。

預計在預測期內，類視色素A細分市場將呈現最高的複合年成長率。

預計在預測期內，類視色素產品將呈現最高的複合年成長率。目前，許多人廣泛使用類視色素來去除堵塞毛孔的多餘油脂和污垢。這種方法被認為安全且副作用少，因此市場規模龐大。類視色素的作用機轉是防止老舊角蛋白（痤瘡的主要成因之一）阻塞毛孔。透過促進細胞更新，類視色素可以預防毛孔堵塞。

市佔率最大的地區：

預計在預測期內，北美將佔據最大的市場佔有率，這主要得益於該地區痤瘡患者數量的增加以及消費者對化妝品日益成長的興趣。隨著主要區域公司推出新產品以及患者數量的顯著成長，市場將持續擴張。隨著創新治療方法和解決方案的日益普及，市場佔有率預計將進一步成長。

複合年成長率最高的地區：

亞太地區預計將在預測期內保持最高的複合年成長率，這主要得益於公眾對多種藥品的認知度不斷提高以及越來越多的公司進入市場。該地區擁有龐大的基本客群，對各種旨在改善膚質的化妝品有廣泛的需求。此外，受氣候影響，色素沉著過度在該地區也被認為是一個重要的健康問題。同時，預測期內消費者藥品使用量的增加也將進一步推動市場成長。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對重點公司進行基準分析。

目錄

第1章：執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章 全球痤瘡治療市場：依產品分類

  • 異維A酸
  • 抗生素
  • 類視色素
  • 其他產品

第6章：全球痤瘡治療市場：依痤瘡類型分類

  • 緩和
  • 溫和的
  • 中度至重度

第7章：全球痤瘡治療市場：依藥物類型分類

  • 處方藥
  • 非處方藥

第8章 全球痤瘡治療市場：依治療方法分類

  • 醫療設備
    • 高頻治療設備
    • 雷射設備
  • 透過治療方法
    • 抗發炎藥
    • 化學換膚
    • 荷爾蒙藥物
    • 類視色素療法
    • 抗生素
  • 其他治療方法

第9章：全球痤瘡治療市場：依給藥途徑分類

  • 口服
  • 注射藥物
  • 外用

第10章 全球痤瘡治療市場：按最終用戶分類

  • 醫療水療中心
  • 皮膚科診所
  • 醫院
  • 其他最終用戶

第11章 全球痤瘡治療市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第12章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第13章：公司簡介

  • Johnson & Johnson Services, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Leo Pharma A/S
  • Stiefel Laboratories, Inc.
  • Bayer AG
  • Roche Holding AG
  • Bausch Health Companies Inc.
  • Galderma Laboratories
  • Hoffman La Roche Ltd
  • Pfizer Inc.
  • Valeant Pharmaceutical International, Inc.
  • GlaxoSmithKline Plc.
  • Cutera Inc.
  • Vyne Therapeutics Inc.
  • Botanix Pharmaceuticals
  • ABBVIE INC.
  • Candela Corporation
  • Almirall, SA
Product Code: SMRC24637

According to Stratistics MRC, the Global Acne Treatment Market is accounted for $13.6 billion in 2026 and is expected to reach $23.6 billion by 2034 growing at a CAGR of 7.1% during the forecast period. Clogged skin pores and openings, including hair follicles, are the cause of acne, a skin-related condition. Teenagers and those in their early adult years are the key demographics that exhibit this arrangement. This is an extremely prevalent skin condition that affects all skin types regardless of age. Antibiotics and retinoids are used in the treatment of this type of skin condition. Even though there is no certainty that treating these skin conditions would provide the desired effects, the industry has long dominated this field due to its cosmetic value.

According to the National Center for Biotechnology Information (NCBI), the prevalence of acne affected 9.4% of the global population in 2022. It is the eighth most prevalent disease in the world.

Market Dynamics:

Driver:

Increasing prevalence of acne

Skin disorders affect a large percentage of people. The worldwide public is becoming more aware of acne products and accessible treatment choices due to the advent of numerous products used for the treatment, such as retinoids, isotretinoids, and oral and topical antibiotics. Therefore, it is anticipated that rising patient awareness would promote market expansion. Effective product marketing to pique the interest of the intended audience is also a key component in driving market expansion.

Restraint:

Concerns about product safety

Treatments for acne might have different side effects according on the dosage and mode of administration. Skin irritation and dryness are the most frequent adverse effects of topical acne medications. More severe adverse effects are possible with oral medicines. Antibiotics may cause nausea or vomiting, as well as dizziness and light headedness. It is anticipated that the safety concerns surrounding acne treatment solutions would impede market expansion.

Opportunity:

Increasing awareness

The demand for minimally invasive cosmetic treatment treatments is increasing. Dermatologists would rather use topical treatments or less invasive techniques to address skin conditions than surgical ones. The need for treatments connected to face and skin-related issues is rising as a result of better decision-making, improved patient-physician connections, and well-documented procedures. This has prompted the use of less painful cosmetic combination treatment methods.

Threat:

High cost of treatment

Effective acne treatments can occasionally be costly, particularly when it comes to prescription drugs or procedures like laser therapy. This is a serious drawback for people with little resources or no insurance. Treatments for acne might not be a one-time expense. The overall cost of some procedures is increased by the need for regular maintenance or follow-up appointments. These factors are hampering the growth of the market.

Covid-19 Impact:

The epidemic slowed the rise of acne medications since fewer people worldwide were seeking treatment. Leading companies in the industry experienced significant revenue losses as a result of COVID-19. Drug sales were also impacted by reduced manufacturing, redistributing healthcare spending, broken supply chains, shutting dermatological clinics, and other issues. The rise in acne occurrences linked to extended usage of medical face masks further contributed to the demand for pharmaceuticals.

The therapeutic devices segment is expected to be the largest during the forecast period

The therapeutic devices segment is expected to be the largest during the forecast period. The development of therapeutic gadgets for the treatment of acne is propelling this industry's expansion. Reducing the visibility of scars from previous acne episodes is the goal of laser therapy for acne scars. Continuous light therapy is applied to the skin's dermis layer to break up scar tissue and promote the growth of new, healthy skin cells to replace the damaged tissue.

The retinoid segment is expected to have the highest CAGR during the forecast period

The retinoid segment is expected to have the highest CAGR during the forecast period. Retinoids are now widely used by people to clear their skin of excess oil and dust that has clogged their open pores. The method is a large market sector since it is regarded as safe and has little negative effects. They function by stopping the main cause of acne, dead skin cells, from obstructing pores. By encouraging cell turnover, retinoid production keeps the pores from becoming clogged.

Region with largest share:

North America is projected to hold the largest market share during the forecast period owing to the region's increasing majority of acne and growing consumer problems related to beauty. The market will grow as a result of the introduction of new products by significant regional companies and a notable increase in the patient population. The market share will increase to a bigger volume as innovative treatments and solutions are used more frequently.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period due to rising awareness among the population about several drugs combined with the increasing number of companies entering the market. The greatest customer base for a variety of cosmetic goods created to achieve clean skin is found in this region. Due to the climate, hyperpigmentation has also been identified as a significant issue in this area. Moreover, growth would be fueled by consumers' increasing medicine usage over the projection period.

Key players in the market

Some of the key players in Acne Treatment market include Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., Leo Pharma A/S, Stiefel Laboratories, Inc., Bayer AG, Roche Holding AG, Bausch Health Companies Inc., Galderma Laboratories, Hoffman La Roche Ltd, Pfizer Inc., Valeant Pharmaceutical International, Inc., GlaxoSmithKline Plc., Cutera Inc., Vyne Therapeutics Inc., Botanix Pharmaceuticals, ABBVIE INC., Candela Corporation and Almirall, S.A.

Key Developments:

In July 2022, Glenmark Pharmaceuticals launched a new acne drug, MINYM gel, in India. This is India's first topical Minocycline 4% Gel to treat acne.

In March 2022, Galderma introduced its breakthrough skincare cream, Twyneo to treat moderate to severe facial acne, to the U.S. market at the American Academy of Dermatology (AAD) Annual Meeting.

In January 2022, GALDERMA announced to receive its antitrust clearance from the U.S. authorities after completing the acquisition of ALASTIN Skincare, Inc. for developing innovative and clinically-tested physician-dispensed skincare products.

Products Covered:

  • Isotretinoi
  • Antibiotics
  • Retinoids
  • Other Products

Acne Types Covered:

  • Moderate
  • Mild
  • Moderate to Severe

Drug Types Covered:

  • Prescription
  • Over the Counter (OTC)

Treatments Covered:

  • Devices
  • Therapeutic Treatment
  • Other Treatments

Route of Administrations Covered:

  • Oral
  • Injectable
  • Topical

End Users Covered:

  • MedSpa
  • Dermatology Clinics
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Acne Treatment Market, By Product

  • 5.1 Introduction
  • 5.2 Isotretinoi
  • 5.3 Antibiotics
  • 5.4 Retinoids
  • 5.5 Other Products

6 Global Acne Treatment Market, By Acne Type

  • 6.1 Introduction
  • 6.2 Moderate
  • 6.3 Mild
  • 6.4 Moderate to Severe

7 Global Acne Treatment Market, By Drug Type

  • 7.1 Introduction
  • 7.2 Prescription
  • 7.3 Over the Counter (OTC)

8 Global Acne Treatment Market, By Treatment

  • 8.1 Introduction
  • 8.2 Devices
    • 8.2.1 Radio frequency Devices
    • 8.2.2 Laser Devices
  • 8.3 Therapeutic Treatment
    • 8.3.1 Anti-inflammatory Drugs
    • 8.3.2 Chemical Peels
    • 8.3.3 Hormonal Drugs
    • 8.3.4 Retinoid Therapy
    • 8.3.8 Antibiotics
  • 8.4 Other Treatments

9 Global Acne Treatment Market, By Route of Administration

  • 9.1 Introduction
  • 9.2 Oral
  • 9.3 Injectable
  • 9.4 Topical

10 Global Acne Treatment Market, By End User

  • 10.1 Introduction
  • 10.2 MedSpa
  • 10.3 Dermatology Clinics
  • 10.4 Hospitals
  • 10.5 Other End Users

11 Global Acne Treatment Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Johnson & Johnson Services, Inc.
  • 13.2 Teva Pharmaceutical Industries Ltd.
  • 13.3 Leo Pharma A/S
  • 13.4 Stiefel Laboratories, Inc.
  • 13.5 Bayer AG
  • 13.6 Roche Holding AG
  • 13.7 Bausch Health Companies Inc.
  • 13.8 Galderma Laboratories
  • 13.9 Hoffman La Roche Ltd
  • 13.10 Pfizer Inc.
  • 13.11 Valeant Pharmaceutical International, Inc.
  • 13.12 GlaxoSmithKline Plc.
  • 13.13 Cutera Inc.
  • 13.14 Vyne Therapeutics Inc.
  • 13.15 Botanix Pharmaceuticals
  • 13.16 ABBVIE INC.
  • 13.17 Candela Corporation
  • 13.18 Almirall, S.A.

List of Tables

  • Table 1 Global Acne Treatment Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Acne Treatment Market Outlook, By Product (2023-2034) ($MN)
  • Table 3 Global Acne Treatment Market Outlook, By Isotretinoi (2023-2034) ($MN)
  • Table 4 Global Acne Treatment Market Outlook, By Antibiotics (2023-2034) ($MN)
  • Table 5 Global Acne Treatment Market Outlook, By Retinoids (2023-2034) ($MN)
  • Table 6 Global Acne Treatment Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 7 Global Acne Treatment Market Outlook, By Acne Type (2023-2034) ($MN)
  • Table 8 Global Acne Treatment Market Outlook, By Moderate (2023-2034) ($MN)
  • Table 9 Global Acne Treatment Market Outlook, By Mild (2023-2034) ($MN)
  • Table 10 Global Acne Treatment Market Outlook, By Moderate to Severe (2023-2034) ($MN)
  • Table 11 Global Acne Treatment Market Outlook, By Drug Type (2023-2034) ($MN)
  • Table 12 Global Acne Treatment Market Outlook, By Prescription (2023-2034) ($MN)
  • Table 13 Global Acne Treatment Market Outlook, By Over the Counter (OTC) (2023-2034) ($MN)
  • Table 14 Global Acne Treatment Market Outlook, By Treatment (2023-2034) ($MN)
  • Table 15 Global Acne Treatment Market Outlook, By Devices (2023-2034) ($MN)
  • Table 16 Global Acne Treatment Market Outlook, By Radio frequency Devices (2023-2034) ($MN)
  • Table 17 Global Acne Treatment Market Outlook, By Laser Devices (2023-2034) ($MN)
  • Table 18 Global Acne Treatment Market Outlook, By Therapeutic Treatment (2023-2034) ($MN)
  • Table 19 Global Acne Treatment Market Outlook, By Anti-inflammatory Drugs (2023-2034) ($MN)
  • Table 20 Global Acne Treatment Market Outlook, By Chemical Peels (2023-2034) ($MN)
  • Table 21 Global Acne Treatment Market Outlook, By Hormonal Drugs (2023-2034) ($MN)
  • Table 22 Global Acne Treatment Market Outlook, By Retinoid Therapy (2023-2034) ($MN)
  • Table 23 Global Acne Treatment Market Outlook, By Antibiotics (2023-2034) ($MN)
  • Table 24 Global Acne Treatment Market Outlook, By Other Treatments (2023-2034) ($MN)
  • Table 25 Global Acne Treatment Market Outlook, By Route of Administration (2023-2034) ($MN)
  • Table 26 Global Acne Treatment Market Outlook, By Oral (2023-2034) ($MN)
  • Table 27 Global Acne Treatment Market Outlook, By Injectable (2023-2034) ($MN)
  • Table 28 Global Acne Treatment Market Outlook, By Topical (2023-2034) ($MN)
  • Table 29 Global Acne Treatment Market Outlook, By End User (2023-2034) ($MN)
  • Table 30 Global Acne Treatment Market Outlook, By MedSpa (2023-2034) ($MN)
  • Table 31 Global Acne Treatment Market Outlook, By Dermatology Clinics (2023-2034) ($MN)
  • Table 32 Global Acne Treatment Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 33 Global Acne Treatment Market Outlook, By Other End Users (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.